Hula Therapeutics
PrivateLast Round
Seed
Jul 19, 2024
Total Funding Raised
$250,000
Company Overview
Hula Therapeutics operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Seed round in July 2024.
Hula Therapeutics is a biotechnology company that develops precision immunotherapies for the treatment of solid tumors in children and adults.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hula Therapeutics Comparables
Compare Hula Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affini-T Therapeutics | 85% | |
| Myrio Therapeutics | 83% | |
| A2 Biotherapeutics | 76% |
For institutional investors. Book with your work email.
Hula Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hula Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioAdvance Capital | Seed |
| Hatch Biofund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors grew 567% MoM, reaching 1K.
- Jul 19, 2024
$250K round led by Hatch Biofund
For institutional investors. Book with your work email.
Hula Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hula Therapeutics's valuation, stock price, and market status.
Is Hula Therapeutics a public or private company?
Hula Therapeutics is a private company.
What is the current stock price of Hula Therapeutics?
Hula Therapeutics is a private company, so its shares have no public market price. Caplight tracks Hula Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hula Therapeutics worth (valuation)?
Valuation information for Hula Therapeutics is not publicly available.
Can I buy Hula Therapeutics stock?
Hula Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hula Therapeutics's last funding round?
Hula Therapeutics's most recent funding round was Seed on July 19, 2024.
Who are the main investors in Hula Therapeutics?
Key investors in Hula Therapeutics include Hatch Biofund.
Will Hula Therapeutics IPO soon?
No public IPO plans have been announced for Hula Therapeutics.
How can I track Hula Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Hula Therapeutics's shares on secondary markets.